Workflow
联盛化学(301212) - 2024 Q3 - 季度财报
RealsunChemRealsunChem(SZ:301212)2024-10-29 10:35

Revenue and Profit - Revenue for Q3 2024 was CNY 127,592,555.68, an increase of 10.25% compared to the same period last year[3] - Net profit attributable to shareholders was CNY -2,918,513.95, a decrease of 134.41% year-on-year[3] - Net profit excluding non-recurring items was CNY -3,586,108.82, down 167.97% from the previous year[3] - Total operating revenue for the current period is CNY 428,499,956.45, a decrease of 17% compared to CNY 516,164,255.38 in the previous period[15] - Net profit for the current period is CNY 13,588,305.39, a significant decrease of 80% from CNY 68,556,581.24 in the previous period[16] - Basic earnings per share for the current period is CNY 0.13, down from CNY 0.62 in the previous period[17] Assets and Liabilities - Total assets at the end of Q3 2024 were CNY 1,646,791,447.69, a decrease of 2.18% from the end of the previous year[3] - The company’s total equity attributable to shareholders was CNY 1,335,706,335.24, a slight decrease of 0.59% from the previous year[3] - The total current assets decreased from ¥978,386,486.11 to ¥757,240,486.53, reflecting a reduction of about 22.6%[12] - The total non-current assets increased from ¥705,127,186.28 to ¥889,550,961.16, indicating a growth of approximately 26.1%[13] - The total liabilities decreased from ¥307,154,263.63 to ¥278,284,341.10, showing a decline of about 9.4%[13] - The total assets decreased from ¥1,683,513,672.39 to ¥1,646,791,447.69, reflecting a reduction of approximately 2.2%[13] Cash Flow - Cash flow from operating activities was CNY -117,338,044.31, a decline of 172.94% compared to the same period last year[3] - The company reported a significant decrease in net cash flow from operating activities, primarily due to lower revenue and delayed payments from major customers[8] - Cash flow from operating activities shows a net outflow of CNY -117,338,044.31, compared to a net inflow of CNY 160,876,172.24 in the previous period[18] - The net cash flow from investment activities was 118,159,050.68 CNY, compared to a negative cash flow of 86,731,880.10 CNY in the previous period[19] - The net cash flow from financing activities was -16,839,952.43 CNY, improving from -36,533,184.26 CNY in the previous period[19] - The net increase in cash and cash equivalents was -15,140,543.06 CNY, contrasting with an increase of 39,285,580.39 CNY in the previous period[19] Expenses and Investments - Research and development expenses decreased by 33.36% to CNY 14,374,762.66 for the first nine months of 2024[8] - Investment income increased by 292.38% to CNY 1,201,763.33 for the first nine months of 2024[8] - Research and development expenses for the current period are CNY 14,374,762.66, down from CNY 21,569,337.80 in the previous period, indicating a reduction of approximately 33%[15] - The company reported a financial expense of CNY -8,923,220.22, significantly improved from CNY -20,366,499.21 in the previous period[15] Shareholder Information - The total number of common shareholders at the end of the reporting period is 7,965[9] - The company has a total of 57,000,000 shares held by Liansheng Chemical Group, accounting for 52.78% of the total shares[10] - The company has a total of 10,000,000 shares held by Mu Jianyu, representing 9.26% of the total shares[10] Other Financial Information - The company received government subsidies amounting to CNY 80,799.46 in Q3 2024[4] - Cash and cash equivalents at the end of the period totaled 151,152,291.47 CNY, down from 289,948,271.82 CNY at the beginning of the period[19] - The cash inflow from investment activities is CNY 676,367,093.27, a substantial increase compared to CNY 118,200,199.87 in the previous period[18] - The cash outflow for dividend payments and interest was 21,448,345.85 CNY, down from 41,245,341.65 CNY in the previous period[19] - The impact of exchange rate changes on cash and cash equivalents was 878,403.00 CNY, compared to 1,674,472.51 CNY in the previous period[19] - The third quarter report was not audited[19]